Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma

Affiliations

• ¹ Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
• ² Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Seoul, Korea.
• ³ Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
• ⁴ Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea.
• ⁵ Division of Hematology-Oncology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
• ⁶ Department of Hematology-Oncology, Keimyung University School of Medicine, Daegu, Korea.
• ⁷ Division of Hematology-Oncology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
• ⁸ Division of Hematology and Medical Oncology, Department of Internal Medicine, Boramae Medical Center, Seoul, Korea.
• ⁹ Division of Hematology-Oncology, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea.